Here, we show that the oncogenic BCR-ABL1 of chronic myelogenous leukemia (CML) and the cellular ABL1 tyrosine kinases phosphorylate and inactivate Smad4 to block antiproliferative TGF-β signaling. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.